Evan Jones

This inventor holds 9 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: The University of Arizona. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Evan Jones. Retrieved from https://idiyas.com/inventor/evan-jones-p9x8wjej

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 9 (Patent Applications = 3)

% Patents Active = 88.9

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 5.4

ph-index = 1

Forward Citations = 4(Granted Patents)

Company Filing History:

9 out of 1,069

The University of Arizona

patents

Years Active: 2017-2025

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12433932 - Ang (1-7) derivative oligopeptides for the treatment of pain (2025-10-07),

2. 12116423 - Ang (1-7) derivative oligopeptides and methods for using and producing the same (2024-10-15),

3. 11104706 - Ang (1-7) derivative oligopeptides and methods for using and producing the same (2021-08-31),

4. 10881708 - Ang (1-7) derivative oligopeptides for the treatment of pain (2021-01-05),

5. 10858410 - Glycosylated peptides with pseudoproline residues and having enhanced half-lives and ability to cross the blood brain barrier (2020-12-08),

6. 10550156 - Ang (1-7) derivative oligopeptides and methods for using and producing the same (2020-02-04),

7. 10183055 - Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications (2019-01-22),

8. 9796759 - Ang-(1-7) derivative oligopeptides and methods for using and producing the same (2017-10-24),

9. 9670251 - ANG-(1-7) derivative oligopeptides and methods for using and producing the same (2017-06-06),

Title: The Innovative Contributions of Evan Jones

Introduction

Evan Jones is a prominent inventor based in Tucson, AZ (US), known for his significant contributions to the field of biomedical research. With a total of 9 patents to his name, he has made remarkable strides in developing innovative solutions for pain management and cognitive dysfunction.

Latest Patents

One of his latest patents focuses on Ang (1-7) derivative oligopeptides for the treatment of pain. This invention provides oligopeptides, particularly Ang-(1-7) derivatives, along with methods for their use and production. In a specific embodiment, these oligopeptides demonstrate higher blood-brain barrier penetration and/or in vivo half-life compared to the native Ang-(1-7). This advancement allows for a wide range of clinical applications, including the treatment of cognitive dysfunction and pain. Another patent also centers on Ang (1-7) derivative oligopeptides, emphasizing their potential in clinical settings.

Career Highlights

Evan Jones is affiliated with the University of Arizona, where he continues to push the boundaries of research and innovation. His work has garnered attention for its potential impact on healthcare and therapeutic practices.

Collaborations

Evan collaborates with notable colleagues, including Robin L Polt and Meredith Hay, who contribute to his research endeavors and enhance the scope of his inventions.

Conclusion

Evan Jones exemplifies the spirit of innovation in the biomedical field, with his patents paving the way for new treatments and therapies. His work not only addresses critical health issues but also showcases the importance of collaboration in advancing scientific knowledge.

Profile summary based on public USPTO records.